Clinical Trial

Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter prospective study to develop and validate a multimodal, deep learning-based model for predicting treatment response in patients with extranodal natural killer/T-cell lymphoma (NKTCL) receiving first-line asparaginase-based therapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-06.
Trial Details
NCT Number NCT07409168
Lead Sponsor Sun Yat-sen University
Conditions Natural Killer/T-cell Lymphoma
Enrollment 100 participants
Start Date 2026-08-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-28